Effect of recombinant human interleukin-3 on haematological recovery from chemotherapy-induced myelosuppression
- 1 August 1994
- journal article
- clinical trial
- Published by Wiley in British Journal of Haematology
- Vol. 87 (4) , 678-686
- https://doi.org/10.1111/j.1365-2141.1994.tb06723.x
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Phase I Clinical Trial of Recombinant Human Interleukin-3 Combined With Carboplatin in the Treatment of Patients With Recurrent Ovarian CarcinomaJNCI Journal of the National Cancer Institute, 1993
- Recombinant granulocyte colony stimulating factor reduces the infectious complications of cytotoxic chemotherapyEuropean Journal Of Cancer, 1993
- Reduction by Granulocyte Colony-Stimulating Factor of Fever and Neutropenia Induced by Chemotherapy in Patients with Small-Cell Lung CancerNew England Journal of Medicine, 1991
- Why clinicians should be interested in Interleukin-3Annals of Hematology, 1990
- Phase I study of granulocyte colony-stimulating factor in patients with transitional cell carcinoma of the urothelium.Journal of Clinical Investigation, 1988
- Human IL-3 and GM-CSF Act Synergistically in Stimulating Hematopoiesis in PrimatesScience, 1988
- Effect of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor on Chemotherapy-Induced MyelosuppressionNew England Journal of Medicine, 1988
- EFFECT OF GRANULOCYTE COLONY STIMULATING FACTOR ON NEUTROPENIA INDUCED BY CYTOTOXIC CHEMOTHERAPYThe Lancet, 1988
- Phase I/II study of recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for small cell lung cancerBritish Journal of Cancer, 1987
- The Human Hematopoietic Colony-Stimulating FactorsScience, 1987